139 related articles for article (PubMed ID: 10737386)
1. Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumours.
Lin SR; Hsu CH; Tsai JH; Wang JY; Hsieh TJ; Wu CH
Br J Cancer; 2000 Mar; 82(5):1035-40. PubMed ID: 10737386
[TBL] [Abstract][Full Text] [Related]
2. High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients.
Wang JY; Hsieh JS; Chen FM; Yeh CS; Alexandersen K; Huang TJ; Chen Dc; Lin SR
Int J Cancer; 2003 Nov; 107(3):387-93. PubMed ID: 14506738
[TBL] [Abstract][Full Text] [Related]
3. Differences in GTPase-activating protein activity between liver tumors and normal liver tissue in mice.
Müller O; Frech M; Gideon P; Wittinghofer A; Schwarz M
Oncogene; 1992 Jul; 7(7):1407-12. PubMed ID: 1620552
[TBL] [Abstract][Full Text] [Related]
4. A glutamic acid residue at position 31 of Ras protein is essential to the signal transduction for neurite outgrowth of PC12 cells and the stimulation of GTPase activity by GAPRas.
Shirouzu M; Fujita-Yoshigaki J; Ito Y; Koide H; Nishimura S; Yokoyama S
Oncogene; 1992 Mar; 7(3):475-80. PubMed ID: 1549361
[TBL] [Abstract][Full Text] [Related]
5. Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras.
Schweins T; Geyer M; Kalbitzer HR; Wittinghofer A; Warshel A
Biochemistry; 1996 Nov; 35(45):14225-31. PubMed ID: 8916907
[TBL] [Abstract][Full Text] [Related]
6. Suppression of c-ras transformation by GTPase-activating protein.
Zhang K; DeClue JE; Vass WC; Papageorge AG; McCormick F; Lowy DR
Nature; 1990 Aug; 346(6286):754-6. PubMed ID: 2201922
[TBL] [Abstract][Full Text] [Related]
7. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
Luo RZ; Fang X; Marquez R; Liu SY; Mills GB; Liao WS; Yu Y; Bast RC
Oncogene; 2003 May; 22(19):2897-909. PubMed ID: 12771940
[TBL] [Abstract][Full Text] [Related]
8. Significantly increased cortisol secretion in normal adrenocortical cells transfected with K-ras mutants derived from human functional adrenocortical tumors.
Hsu CH; Yang YC; Lian ST; Lee SC; Shin SJ; Tsai JH; Lin SR
DNA Cell Biol; 2001 Apr; 20(4):231-8. PubMed ID: 11403720
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of the Ras GTPase activating protein catalytic domain by semirandom mutagenesis: implications for a mechanism of interaction with Ras-GTP.
Hettich L; Marshall M
Cancer Res; 1994 Oct; 54(20):5438-44. PubMed ID: 7923177
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
Marshall MS; Hettich LA
Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
[TBL] [Abstract][Full Text] [Related]
11. PCR-SSCP analysis of human adrenocortical adenomas: absence of K-ras gene mutations.
Ocker M; Sachse R; Rico A; Hensen J
Exp Clin Endocrinol Diabetes; 2000; 108(8):513-4. PubMed ID: 11149627
[TBL] [Abstract][Full Text] [Related]
12. Real-time in vitro measurement of intrinsic and Ras GAP-mediated GTP hydrolysis.
Shutes A; Der CJ
Methods Enzymol; 2006; 407():9-22. PubMed ID: 16757310
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of ras GTPase activity by an anti-ras monoclonal antibody.
Agellon S; Stone JC
Mol Carcinog; 1996 Jul; 16(3):132-8. PubMed ID: 8688148
[TBL] [Abstract][Full Text] [Related]
14. The GAP1 family of GTPase-activating proteins: spatial and temporal regulators of small GTPase signalling.
Yarwood S; Bouyoucef-Cherchalli D; Cullen PJ; Kupzig S
Biochem Soc Trans; 2006 Nov; 34(Pt 5):846-50. PubMed ID: 17052212
[TBL] [Abstract][Full Text] [Related]
15. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulations of Gly-12-->Val mutant of p21(ras): dynamic inhibition mechanism.
Futatsugi N; Tsuda M
Biophys J; 2001 Dec; 81(6):3483-8. PubMed ID: 11721009
[TBL] [Abstract][Full Text] [Related]
17. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma.
Ruíz-Godoy R LM; Garcia-Cuellar CM; Herrera González NE; Suchil BL; Pérez-Cárdenas E; Sácnchez-Pérez Y; Suárez-Roa ML; Meneses A
J Exp Clin Cancer Res; 2006 Mar; 25(1):73-8. PubMed ID: 16761621
[TBL] [Abstract][Full Text] [Related]
19. Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase.
Fischbach MA; Settleman J
Cancer Res; 2003 Jul; 63(14):4089-94. PubMed ID: 12874011
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
